Return to homepagePandemic Pact

Central IRB Services for NIAID Coronavirus COVID-19 OWS ACTIV-3 Clinical Trial

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 272201500015I-0-759302000017-3

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2021

  • Known Financial Commitments (USD)

    $718,961

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    ANNA MAHYERA

  • Research Location

    United States of America

  • Lead Research Institution

    MEDICAL SCIENCE & COMPUTING, LLC

  • Research Priority Alignment

    N/A

  • Research Category

    Research to inform ethical issues

  • Research Subcategory

    Research to inform ethical issues in Research

  • Special Interest Tags

    N/A

  • Study Type

    Not applicable

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    N/A

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The purpose of this funding is to provide the Central Institutional Review Board (IRB) services for the Coronavirus COVID-19 ACTIV-3 trial.